Indo Borax & Chemicals LtdQ4 FY26
Indo Borax & Chemicals Ltd Q4 FY26 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Price: ₹488P/E: 27.9Market Cap: ₹1.4K CrSector: Chemicals & Petrochemicals
Management growth scorecard
Revenue
Category 2
Margin
Category 3
Fundraise
N/A
Order
N/A
Capex
Yes
1 of 3 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
Category 2- →The company achieved Rs. 175 crores revenue in the previous financial year and Rs. 215 crores in FY26, showing strong growth.
- →Management expects revenue growth between 20% to 35% in the coming years, driven by increased realisation, higher volumes from debottlenecking, operational efficiency, and new products.
- →Full capacity utilisation may boost revenue by 25% to 30% without additional CAPEX within one to one and a half years.
- →Sales volume growth and better price realisations are expected, especially in Boric Acid and DOT products.
- →Plans for expanding into new product lines, such as Boron Oxide, are underway to tap further growth opportunities.
- →Boric Acid volumes have grown from 600 tons to about 980 tons recently, with a target to reach 1,500 tons next year.
- →Exploration into new-age applications and export markets is ongoing, expected to materialise in the coming quarters.
Margin guidance
Category 3- →The company showed revenue growth from Rs.175 crores to Rs.215 crores between recent financial years, expecting 20%-35% revenue growth going forward, driven by increased realization, higher volumes through debottlenecking, operational efficiency, and new products.
- →EBITDA margins are targeted to be maintained or improved; current EBITDA margins are around 20%-21%.
- →Net profit (PAT) increased 41.9% to Rs.14.53 crores in Q4 FY26; annual PAT was Rs.50.27 crores versus Rs.42.51 crores prior year.
- →EPS stood at Rs.4.53 for Q4 FY26 and Rs.15.67 for FY26.
- →Management expects sales to reach Rs.250+ crores next year, with sustained or improved earnings quality.
- →Focus on sustainable long-term growth through capacity expansion, new product lines (Boron Oxide, Boric Acid I.P. Grade, DOT), and exploration of new market segments.
- →Continued transparent updates and investor engagement committed by management.
3 more insights locked — sign up free to unlock
Fundraise plans
- →No explicit mention of new fundraising through debt or equity in the provided text.
- →The company currently has zero debt (Page 21).
- →They have sufficient cash for planned CAPEX and growth (Page 12, 13).
- →Cash from matured fixed deposits is being reinvested into liquid mutual funds to maintain liquidity for CAPEX and opportunities (Page 22).
- →Discussions around capacity expansion and potential acquisitions indicate use of internal cash flows rather than new debt or equity (Page 12, 16).
- →No stated plans or guidance about issuing new equity or taking fresh debt during the current reporting period (Page 12, 13, 21).
- →Focus remains on sustainable growth, operational efficiency, and expanding product lines using existing resources.
Order book
The document does not explicitly mention the details of the current or expected order book or pending orders for Indo Borax & Chemicals Limited. However, the following points related to business outlook and growth can be noted:
- The company is confident about sustaining and growing revenues, expecting 20% to 35% revenue growth in the coming period.
- Capacity utilization is increasing, especially for Boric Acid and DOT products.
- Debottlenecking efforts are underway to increase capacity and volumes.
- New product lines like Boron Oxide are expected to start contributing in 3-4 quarters.
- The company is exploring export markets to expand its customer base.
- Management expresses optimism on maintaining EBITDA margins and quality of earnings with improving volumes and realizations.
No specific figures or details regarding pending orders or order book size are provided.
Capex plans
Yes- →The company is actively pushing ahead with CAPEX plans to expand capacity and broaden the product portfolio; details will be shared post board approval as discussions are ongoing (Page 4).
- →Sufficient cash is available for budgeted CAPEX over the next two years while maintaining a strong balance sheet with zero debt (Page 12).
- →The management is monetizing non-core assets to fund future technologies and investments (Page 12).
- →There are strategic discussions about potential acquisitions or further investments, supported by Zenrock Chemicals' experience and cash availability (Page 11-12).
- →Debottlenecking and operational efficiency improvements are planned to increase volumes without major CAPEX in the near term (Page 25).
- →Exploration of new product lines and forward integration opportunities within boron chemistry is underway, aiming at growth through both domestic and export markets (Pages 4, 15, 27).
- →The leadership is focused on sustainable long-term growth with transparent investor communication (Page 28).
How does Indo Borax & Chemicals Ltd rank vs peers in Chemicals & Petrochemicals?
Pro feature1Indo Borax & Chemicals Ltd
Rev 2Mar 3
See full Chemicals & Petrochemicals sector rankings
How does Indo Borax & Chemicals Ltd rank in Chemicals & Petrochemicals?
Compare Indo Borax & Chemicals Ltd against every Chemicals & Petrochemicals company (Q4 FY26) on revenue, margins and earnings-call signals.